249 related articles for article (PubMed ID: 31669890)
1. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis.
Feng M; Guo H; Zhang C; Wang Y; Liang Z; Zhao X; Qin Y; Wu Y; Liu G; Gao C; Luo J
Int Immunopharmacol; 2019 Dec; 77():105912. PubMed ID: 31669890
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory biomarkers in polymyositis/dermatomyositis patients with interstitial lung disease: a retrospective study.
Zhao J; Guo XJ; Shi L
Curr Med Res Opin; 2024 Jan; 40(1):113-122. PubMed ID: 37938089
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of peripheral blood lymphocyte subsets in patients with polymyositis and dermatomyositis.
Wang DX; Lu X; Zu N; Lin B; Wang LY; Shu XM; Ma L; Wang GC
Clin Rheumatol; 2012 Dec; 31(12):1691-7. PubMed ID: 22933126
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of lymphocyte subpopulations and TH1/TH2 balance in patients with polymyositis and dermatomyositis.
Ishii W; Matsuda M; Shimojima Y; Itoh S; Sumida T; Ikeda S
Intern Med; 2008; 47(18):1593-9. PubMed ID: 18797118
[TBL] [Abstract][Full Text] [Related]
5. Low-dose IL-2 therapy restores imbalance between Th17 and regulatory T cells in patients with the dermatomyositis combined with EBV/CMV viremia.
Zheng X; Su R; Hu F; Liu Y; Li X; Gao C; Wang C
Autoimmun Rev; 2022 Nov; 21(11):103186. PubMed ID: 36084894
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-35: A Serological Biomarker for Patients with Polymyositis/Dermatomyositis.
Jiang Q; Li Y; Xia L; Shen H; Lu J
J Interferon Cytokine Res; 2019 Nov; 39(11):720-725. PubMed ID: 31274382
[TBL] [Abstract][Full Text] [Related]
7. Potential role of autophagy in T‑cell survival in polymyositis and dermatomyositis.
Shu X; Chen F; Peng Q; Lu X; Tian X; Wang Y; Wang G
Mol Med Rep; 2017 Aug; 16(2):1180-1188. PubMed ID: 28586060
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
[TBL] [Abstract][Full Text] [Related]
9. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
[TBL] [Abstract][Full Text] [Related]
10. Altered chemokine receptor expression in the peripheral blood lymphocytes in polymyositis and dermatomyositis.
Zhu Z; Yang C; Wang J; Feng Q; Chen Q; Yang P
Cytokine; 2017 Nov; 99():316-321. PubMed ID: 28869080
[TBL] [Abstract][Full Text] [Related]
11. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.
Aleksza M; Szegedi A; Antal-Szalmás P; Irinyi B; Gergely L; Ponyi A; Hunyadi J; Sipka S; Zeher M; Szegedi G; Dankó K
Ann Rheum Dis; 2005 Oct; 64(10):1485-9. PubMed ID: 15829578
[TBL] [Abstract][Full Text] [Related]
12. T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.
Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmström V; Reed AM; Lundberg IE; Padyukov L
Arthritis Res Ther; 2018 Aug; 20(1):188. PubMed ID: 30157932
[TBL] [Abstract][Full Text] [Related]
13. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production.
Sugiura T; Kawaguchi Y; Harigai M; Takagi K; Ohta S; Fukasawa C; Hara M; Kamatani N
J Immunol; 2000 Jun; 164(12):6593-600. PubMed ID: 10843719
[TBL] [Abstract][Full Text] [Related]
14. Increased serum soluble interleukin-2 receptor levels in dermatomyositis are associated with Th17/Treg immune imbalance.
Xie Y; Zhang T; Su R; Liu L; Jiang L; Xue H; Gao C; Li X; Wang C
Clin Exp Med; 2023 Nov; 23(7):3605-3617. PubMed ID: 37528249
[TBL] [Abstract][Full Text] [Related]
15. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
Chen F; Shu XM; Wang DX; Xie Y; Wang GC
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
[TBL] [Abstract][Full Text] [Related]
17. Effects of conventional immunosuppressive treatment on CD244+ (CD28null) and FOXP3+ T cells in the inflamed muscle of patients with polymyositis and dermatomyositis.
Pandya JM; Loell I; Hossain MS; Zong M; Alexanderson H; Raghavan S; Lundberg IE; Malmström V
Arthritis Res Ther; 2016 Apr; 18():80. PubMed ID: 27039301
[TBL] [Abstract][Full Text] [Related]
18. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis.
Kurasawa K; Nawata Y; Takabayashi K; Kumano K; Kita Y; Takiguchi Y; Kuriyama T; Sueishi M; Saito Y; Iwamoto I
Clin Exp Immunol; 2002 Sep; 129(3):541-8. PubMed ID: 12197897
[TBL] [Abstract][Full Text] [Related]
19. Absolute decrease in regulatory T cells and low-dose interleukin-2 therapy: restoring and expanding regulatory T cells to treat systemic sclerosis: a 24-week study.
Yu Z; Cheng H; Ding T; Liang Y; Yan C; Gao C; Wen H
Clin Exp Dermatol; 2022 Dec; 47(12):2188-2195. PubMed ID: 36184784
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
Gabay C; Gay-Croisier F; Roux-Lombard P; Meyer O; Maineti C; Guerne PA; Vischer T; Dayer JM
Arthritis Rheum; 1994 Dec; 37(12):1744-51. PubMed ID: 7986220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
